secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001193125-23-199683
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Inovio cuts 30% of workforce (58 employees) in reorganization plan; expects $2.1M charge, $9.9M annual savings
--------------------------------------------------------------------------------

- Reduction in force of 58 employees (~30% of full-time employees) committed on July 31, 2023.
- One-time pre-tax charge of ~$2.1M in Q3 2023 mainly for severance and benefits.
- Expects annual cost savings of ~$9.9M from the restructuring.
- Cash payments for severance expected by October 31, 2023; charges incurred by Sept 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312523199683/0001193125-23-199683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312523199683/d519359d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-199683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer